Enedra is harnessing the power of synthetic lethality and advanced computational Systems Biology to create therapeutics that work against the complexity, biological and mutational heterogeneity of cancer.
Focus: Drug discovery platform
Team: Andreas Ballis and Alex Gutteridge
Spaces are limited to a maximum of 10 companies per cohort. Contact Marco to know more or to apply.Contact Marco
Copyright © 2023 Stevenage Bioscience Catalyst